Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	trans-synaptic signaling, modulating synaptic transmission	EPHB2 CBLN4 NEO1 CBLN2 CBLN1	9.66e-08	26	92	5	GO:0099550
GeneOntologyCellularComponent	apical plasma membrane	CACNA1D NRG1 BMPR2 SLC36A1 ANK2 SLC26A2 CSPG4 CD44 ADAM17 MUC4	5.61e-05	487	92	10	GO:0016324
GeneOntologyCellularComponent	apical part of cell	CHL1 CACNA1D NRG1 BMPR2 SLC36A1 ANK2 SLC26A2 CSPG4 CD44 ADAM17 MUC4	5.77e-05	592	92	11	GO:0045177
GeneOntologyCellularComponent	synaptic cleft	CBLN4 CBLN2 CBLN1	4.09e-04	33	92	3	GO:0043083
Domain	-	GTF2IRD2B GTF2IRD2	1.46e-04	4	93	2	3.90.1460.10
Domain	GTF2I	GTF2IRD2B GTF2IRD2	1.46e-04	4	93	2	PS51139
Domain	GTF2I	GTF2IRD2B GTF2IRD2	1.46e-04	4	93	2	PF02946
Domain	GTF2I	GTF2IRD2B GTF2IRD2	1.46e-04	4	93	2	IPR004212
Domain	BRK	SMARCA2 CHD9	3.63e-04	6	93	2	SM00592
Domain	BRK_domain	SMARCA2 CHD9	3.63e-04	6	93	2	IPR006576
Domain	BRK	SMARCA2 CHD9	3.63e-04	6	93	2	PF07533
Domain	C1Q	CBLN4 CBLN2 CBLN1	5.34e-04	32	93	3	SM00110
Domain	C1q	CBLN4 CBLN2 CBLN1	5.34e-04	32	93	3	PF00386
Domain	C1q_dom	CBLN4 CBLN2 CBLN1	6.40e-04	34	93	3	IPR001073
Domain	C1Q	CBLN4 CBLN2 CBLN1	6.40e-04	34	93	3	PS50871
Pubmed	Parcellation of cerebellins 1, 2, and 4 among different subpopulations of dorsal horn neurons in mouse spinal cord.	CBLN4 CBLN2 CBLN1	1.91e-08	3	94	3	23853053
Pubmed	Genetic Ablation of All Cerebellins Reveals Synapse Organizer Functions in Multiple Regions Throughout the Brain.	CBLN4 CBLN2 CBLN1	1.91e-08	3	94	3	29691328
Pubmed	Cerebellins are differentially expressed in selective subsets of neurons throughout the brain.	CBLN4 CBLN2 CBLN1	1.91e-08	3	94	3	28714144
Pubmed	Characterization of a transneuronal cytokine family Cbln--regulation of secretion by heteromeric assembly.	CBLN4 CBLN2 CBLN1	7.63e-08	4	94	3	17331201
Pubmed	Cbln family proteins promote synapse formation by regulating distinct neurexin signaling pathways in various brain regions.	CBLN4 CBLN2 CBLN1	7.63e-08	4	94	3	21410790
Pubmed	Distinct expression of Cbln family mRNAs in developing and adult mouse brains.	CBLN4 CBLN2 CBLN1	7.63e-08	4	94	3	16930405
Pubmed	Glutamate receptor δ1 induces preferentially inhibitory presynaptic differentiation of cortical neurons by interacting with neurexins through cerebellin precursor protein subtypes.	CBLN4 CBLN2 CBLN1	7.63e-08	4	94	3	22191730
Pubmed	Cbln1 is essential for interaction-dependent secretion of Cbln3.	CBLN4 CBLN2 CBLN1	7.63e-08	4	94	3	17030622
Pubmed	Distinct neurexin-cerebellin complexes control AMPA- and NMDA-receptor responses in a circuit-dependent manner.	CBLN4 CBLN2 CBLN1	1.90e-07	5	94	3	36205393
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	BMPR2 USF3 MAP1B AOPEP PLEKHG3 KIZ RIN2 KAT6A SMARCA2 HIPK2 CHD9 AKAP13 QSER1 PNPLA7 KLKP1 TTC3 SMG6	4.61e-07	1489	94	17	28611215
Pubmed	Cbln1 Directs Axon Targeting by Corticospinal Neurons Specifically toward Thoraco-Lumbar Spinal Cord.	CBLN4 CBLN2 CBLN1	6.64e-07	7	94	3	36823038
Pubmed	Glycosylation of Cblns attenuates their receptor binding.	CBLN4 CBLN2 CBLN1	6.64e-07	7	94	3	29782851
Pubmed	Differential interactions of cerebellin precursor protein (Cbln) subtypes and neurexin variants for synapse formation of cortical neurons.	CBLN4 CBLN2 CBLN1	1.59e-06	9	94	3	21356198
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	RAF1 NRG1 PTPN3 NEO1 ANK2 SLC26A2 EXPH5 CSPG4 CD44 GAB1	3.35e-06	569	94	10	30639242
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	EPHB2 RAF1 PTPN3 REPS1 MAP1B JADE3 RBM4B CAMK2G RIN2 HIPK2 CPLANE1 GATAD2B	6.40e-06	910	94	12	36736316
Pubmed	A human MAP kinase interactome.	CASP8AP2 PTPN3 USF3 EXPH5 RBM4B HIPK2 AKAP13 CPLANE1 GAB1	7.02e-06	486	94	9	20936779
Pubmed	Frequent loss of Brm expression in gastric cancer correlates with histologic features and differentiation state.	VILL SMARCA2	7.23e-06	2	94	2	18006815
Pubmed	Cbln2 and Cbln4 are expressed in distinct medial habenula-interpeduncular projections and contribute to different behavioral outputs.	CBLN4 CBLN2	7.23e-06	2	94	2	30287486
Pubmed	Atrial fibrillation and sinus node dysfunction in human ankyrin-B syndrome: a computational analysis.	CACNA1D ANK2	7.23e-06	2	94	2	23436330
Pubmed	DACH1 suppresses breast cancer as a negative regulator of CD44.	CD44 DACH1	7.23e-06	2	94	2	28659634
Pubmed	Distinct Intracellular Domain Substrate Modifications Selectively Regulate Ectodomain Cleavage of NRG1 or CD44.	NRG1 CD44	7.23e-06	2	94	2	26217011
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	7.23e-06	2	94	2	23544943
Pubmed	The Cbln family of proteins interact with multiple signaling pathways.	CBLN4 CBLN1	7.23e-06	2	94	2	22220752
Pubmed	Evidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1.	PTPN3 ADAM17	7.23e-06	2	94	2	12207026
Pubmed	Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation.	CACNA1D ANK2	7.23e-06	2	94	2	21859974
Pubmed	Expression of the neural stem cell markers NG2 and L1 in human angiomyolipoma: are angiomyolipomas neoplasms of stem cells?	CHL1 CSPG4	7.23e-06	2	94	2	17592550
Pubmed	Transsynaptic cerebellin 4-neogenin 1 signaling mediates LTP in the mouse dentate gyrus.	CBLN4 NEO1	7.23e-06	2	94	2	35544694
Pubmed	Growth factor and co-receptor release by structural regulation of substrate metalloprotease accessibility.	NRG1 CD44	7.23e-06	2	94	2	27876763
Pubmed	ADAM17-mediated CD44 cleavage promotes orasphere formation or stemness and tumorigenesis in HNSCC.	CD44 ADAM17	7.23e-06	2	94	2	24403253
Pubmed	Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease.	CACNA1D ANK2	7.23e-06	2	94	2	18832177
Pubmed	Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.	GTF2IRD2B GTF2IRD2	7.23e-06	2	94	2	15388857
Pubmed	Cerebellin-2 regulates a serotonergic dorsal raphe circuit that controls compulsive behaviors.	CBLN2 CBLN1	7.23e-06	2	94	2	34158618
Pubmed	Mammalian Otolin: a multimeric glycoprotein specific to the inner ear that interacts with otoconial matrix protein Otoconin-90 and Cerebellin-1.	CBLN4 CBLN2 CBLN1	1.26e-05	17	94	3	20856818
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	OVGP1 MUC16 MUC4	1.51e-05	18	94	3	18834073
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RAF1 ARFGAP2 PTPN3 BMPR2 MAP1B PLEKHG3 EXPH5 TET1 AKAP13 GAB1 AHNAK2	2.14e-05	861	94	11	36931259
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC4	2.16e-05	3	94	2	23053434
Pubmed	Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma.	CD44 MUC16	2.16e-05	3	94	2	12893366
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC4	2.16e-05	3	94	2	30236127
Pubmed	Mitochondrial fission promotes cell migration by Ca2+ /CaMKII/ERK/FAK pathway in hepatocellular carcinoma.	EPHB2 CAMK2G	2.16e-05	3	94	2	29210177
Pubmed	ARIA/HRG regulates AChR epsilon subunit gene expression at the neuromuscular synapse via activation of phosphatidylinositol 3-kinase and Ras/MAPK pathway.	RAF1 NRG1	2.16e-05	3	94	2	8707830
Pubmed	Autophagy regulates cisplatin-induced stemness and chemoresistance via the upregulation of CD44, ABCB1 and ADAM17 in oral squamous cell carcinoma.	CD44 ADAM17	2.16e-05	3	94	2	29171106
Pubmed	Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).	MUC16 MUC4	2.16e-05	3	94	2	27483328
Pubmed	MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.	MUC16 MUC4	2.16e-05	3	94	2	24204560
Pubmed	MAP kinase pathway-dependent phosphorylation of the L1-CAM ankyrin binding site regulates neuronal growth.	CHL1 ANK2	2.16e-05	3	94	2	16597699
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC4	2.16e-05	3	94	2	24939955
Pubmed	Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.	MUC16 MUC4	2.16e-05	3	94	2	17592322
Pubmed	Isolation and characterisation of GTF2IRD2, a novel fusion gene and member of the TFII-I family of transcription factors, deleted in Williams-Beuren syndrome.	GTF2IRD2B GTF2IRD2	2.16e-05	3	94	2	15100712
Pubmed	Vimentin regulates peripheral nerve myelination.	NRG1 ADAM17	2.16e-05	3	94	2	22357929
Pubmed	Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.	MUC16 MUC4	2.16e-05	3	94	2	35879412
Pubmed	TACE (ADAM17) inhibits Schwann cell myelination.	NRG1 ADAM17	2.16e-05	3	94	2	21666671
Pubmed	Comparison of Cbln1 and Cbln2 functions using transgenic and knockout mice.	CBLN2 CBLN1	2.16e-05	3	94	2	22117778
Pubmed	Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.	CSPG4 CD44	2.16e-05	3	94	2	28945172
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	DOCK3 RAF1 ZMYND11 USF3 AKAP13 GAB1 LRRFIP1 KPNB1	2.25e-05	430	94	8	35044719
Pubmed	Mapping of Cbln1-like immunoreactivity in adult and developing mouse brain and its localization to the endolysosomal compartment of neurons.	CBLN4 CBLN2 CBLN1	3.26e-05	23	94	3	18001291
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	VILL AOPEP TUT7 TET1 HIPK2 HMGXB3 ADAM17 QSER1 PJA1 CPLANE1 TTC3 TASOR	3.60e-05	1084	94	12	11544199
Pubmed	Multifaceted Regulation of Akt by Diverse C-Terminal Post-translational Modifications.	REPS1 CTDP1 GAB1 CMTM8	3.78e-05	69	94	4	34941261
Pubmed	Grb2-associated binder-1 is required for neuregulin-1-induced peripheral nerve myelination.	NRG1 GAB1	4.32e-05	4	94	2	24872569
Pubmed	Evolution of general transcription factors.	GTF2IRD2B GTF2IRD2	4.32e-05	4	94	2	23229069
Pubmed	GTF2IRD2 from the Williams-Beuren critical region encodes a mobile-element-derived fusion protein that antagonizes the action of its related family members.	GTF2IRD2B GTF2IRD2	4.32e-05	4	94	2	22899722
Pubmed	Neuregulin-1 modulates the differentiation of neural stem cells in vitro through an interaction with the Swi/Snf complex.	NRG1 SMARCA2	4.32e-05	4	94	2	19781646
Pubmed	Haploinsufficiency of c-Met in cd44-/- mice identifies a collaboration of CD44 and c-Met in vivo.	CD44 GAB1	4.32e-05	4	94	2	17923692
Pubmed	TRPV4 activation in human corneal epithelial cells promotes membrane mucin production.	MUC16 MUC4	4.32e-05	4	94	2	39024979
Pubmed	Cooperative interaction of hepatocyte growth factor and neuregulin regulates Schwann cell migration and proliferation through Grb2-associated binder-2 in peripheral nerve repair.	NRG1 GAB1	4.32e-05	4	94	2	28722233
Pubmed	TFII-I gene family during tooth development: candidate genes for tooth anomalies in Williams syndrome.	GTF2IRD2B GTF2IRD2	4.32e-05	4	94	2	17823943
Pubmed	The mucin Muc4 potentiates neuregulin signaling by increasing the cell-surface populations of ErbB2 and ErbB3.	NRG1 MUC4	4.32e-05	4	94	2	16690615
Pubmed	Ectodomain shedding of the neural recognition molecule CHL1 by the metalloprotease-disintegrin ADAM8 promotes neurite outgrowth and suppresses neuronal cell death.	CHL1 ADAM17	4.32e-05	4	94	2	14761956
Pubmed	SerThr-PhosphoProteome of Brain from Aged PINK1-KO+A53T-SNCA Mice Reveals pT1928-MAP1B and pS3781-ANK2 Deficits, as Hub between Autophagy and Synapse Changes.	ANK2 MAP1B	4.32e-05	4	94	2	31277379
Pubmed	Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.	GTF2IRD2B GTF2IRD2	4.32e-05	4	94	2	21328569
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DOCK3 REPS1 CSPG4 KAT6A CTDP1 AKAP13 HMGXB3 TTC3 PHC2 AHNAK2 SMG6 BAHCC1	4.33e-05	1105	94	12	35748872
Pubmed	CD44s is a crucial ATG7 downstream regulator for stem-like property, invasion, and lung metastasis of human bladder cancer (BC) cells.	TET1 CD44	7.19e-05	5	94	2	30635654
Pubmed	Gab family proteins are essential for postnatal maintenance of cardiac function via neuregulin-1/ErbB signaling.	NRG1 GAB1	7.19e-05	5	94	2	17571162
Pubmed	Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.	CD44 GAB1	7.19e-05	5	94	2	12748184
Pubmed	Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.	EPHB2 RAF1	7.19e-05	5	94	2	11585923
Pubmed	EGF receptor transactivation and PI3-kinase mediate stimulation of ERK by alpha(2A)-adrenoreceptor in intestinal epithelial cells: a role in wound healing.	EPHB2 ADAM17	7.19e-05	5	94	2	17655843
Pubmed	Hyaluronic acid promotes angiogenesis by inducing RHAMM-TGFβ receptor interaction via CD44-PKCδ.	EPHB2 CD44	7.19e-05	5	94	2	22610405
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	PTPN3 BMPR2 SLC26A2 CSPG4 CD44 DLG2 GAB1	7.58e-05	377	94	7	38117590
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	BBX JADE3 DACH1 SMARCA2 CHD9 GATAD2B PHC2 KPNB1	1.01e-04	533	94	8	30554943
Pubmed	A mammalian protein kinase with potential for serine/threonine and tyrosine phosphorylation is related to cell cycle regulators.	EPHB2 AOX1	1.08e-04	6	94	2	1825055
Pubmed	Distinct expression of C1q-like family mRNAs in mouse brain and biochemical characterization of their encoded proteins.	CBLN2 CBLN1	1.08e-04	6	94	2	20525073
Pubmed	A neuronal PI(3,4,5)P3-dependent program of oligodendrocyte precursor recruitment and myelination.	NRG1 CSPG4	1.08e-04	6	94	2	27775720
Pubmed	Six post-implantation lethal knockouts of genes for lipophilic MAPK pathway proteins are expressed in preimplantation mouse embryos and trophoblast stem cells.	RAF1 GAB1	1.08e-04	6	94	2	15736129
Pubmed	A Leishmania major response locus identified by interval-specific congenic mapping of a T helper type 2 cell bias-controlling quantitative trait locus.	BBX CIITA	1.08e-04	6	94	2	15596523
Pubmed	New insights into the function and regulation of vitamin D target proteins.	CACNA1D SMARCA2	1.08e-04	6	94	2	17257825
Pubmed	Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance.	CAMK2G DACH1	1.08e-04	6	94	2	27239042
Pubmed	Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells.	RAF1 CD44	1.08e-04	6	94	2	16565089
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	PRPF4 SMARCA2 CHD9 QSER1 PHC2 SMG6	1.21e-04	282	94	6	23667531
Pubmed	Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.	CLIP3 KAT6A CTDP1 AKAP13 TTC3 KPNB1	1.23e-04	283	94	6	18854154
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	GTF2IRD2B BBX ANK2 MAP1B CAMK2G CSPG4 GTF2IRD2 DLG2 TTC3 RNF17 TASOR KPNB1 BAHCC1	1.34e-04	1442	94	13	35575683
Pubmed	EphB regulates L1 phosphorylation during retinocollicular mapping.	EPHB2 CHL1	1.50e-04	7	94	2	22579729
Pubmed	CHD5, a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates expression of neuronal genes.	DOCK3 GATAD2B	1.50e-04	7	94	2	21931736
Pubmed	Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding.	EPHB2 ADAM17	1.50e-04	7	94	2	12058067
Pubmed	Global genetic analysis in mice unveils central role for cilia in congenital heart disease.	BMPR2 PKD1L1 CPLANE1 ZBTB14	1.61e-04	100	94	4	25807483
Pubmed	Lrig2 Negatively Regulates Ectodomain Shedding of Axon Guidance Receptors by ADAM Proteases.	NEO1 ADAM17	2.00e-04	8	94	2	26651291
Pubmed	Essential role for ADAM19 in cardiovascular morphogenesis.	NRG1 ADAM17	2.00e-04	8	94	2	14673146
Pubmed	New insights into BS69 functions.	ZMYND11 SMARCA2	2.00e-04	8	94	2	16565076
Pubmed	Defects in Synaptic Plasticity, Reduced NMDA-Receptor Transport, and Instability of Postsynaptic Density Proteins in Mice Lacking Microtubule-Associated Protein 1A.	MAP1B DLG2	2.00e-04	8	94	2	26609151
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	RAF1 ZMYND11 PRPF4 KAT6A AOX1 SMARCA2 CHD9 ADAM17 GATAD2B ARMC6 BAHCC1	2.15e-04	1116	94	11	31753913
Pubmed	Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin Dynamics.	PRPF4 SMARCA2 GATAD2B	2.18e-04	43	94	3	26030138
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ZMYND11 BBX JADE3 KAT6A CTHRC1 CHD9 QSER1 GATAD2B	2.48e-04	608	94	8	36089195
Pubmed	WT1-mediated gene regulation in early urogenital ridge development.	CBLN4 MUC16 CBLN1	2.50e-04	45	94	3	18391535
Interaction	CBLN3 interactions	CBLN4 CBLN2 CBLN1	3.92e-07	4	94	3	int:CBLN3
GeneFamily	CD molecules\|Mucins	OVGP1 MUC16 MUC4	4.43e-05	21	60	3	648
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	CSPG4 CD44	2.25e-04	7	60	2	570
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	EPHB2 NRG1 ZMYND11 MGAT5 BBX MAP1B RIN2 KAT6A SMARCA2 CHD9 AKAP13 ADAM17 TASOR PPM1B LRRFIP1	3.82e-07	856	94	15	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	NRG1 ZMYND11 MGAT5 BBX MAP1B KAT6A SMARCA2 CHD9 TASOR PPM1B	6.83e-06	466	94	10	M13522
Coexpression	GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN	OVGP1 KIZ TET1 QSER1 PNPLA7 TTC3	2.64e-05	162	94	6	M7002
Coexpression	MURARO_PANCREAS_BETA_CELL	CHL1 CACNA1D PTPN3 ZMYND11 NEO1 USF3 BBX MAP1B EXPH5 CHD9 TTC3 PHC2 CMTM8	3.28e-05	946	94	13	M39169
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500	CACNA1D CLIP3 MAP1B HIPK2 CPLANE1 GATAD2B KPNB1	3.34e-06	149	90	7	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500	CHL1 CACNA1D CLIP3 MAP1B DACH1 HIPK2 CPLANE1 GATAD2B KPNB1 ARMH4	8.76e-06	407	90	10	gudmap_developingLowerUrinaryTract_e14.5_ urethra_500
ToppCell	NS-moderate-d_0-4-Epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 PTPN3 AOPEP EXPH5 MUC16 CPLANE1 TTC3 MUC4	1.06e-08	200	94	8	64462a18afca3c1a8548a857924b8166058bf958
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 PTPN3 AOPEP EXPH5 MUC16 CPLANE1 MUC4 AHNAK2	1.06e-08	200	94	8	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	CACNA1D CLIP3 CBLN4 COL15A1 MAP1B CTHRC1 ARMH4	9.93e-08	177	94	7	cdfd2f0ee2f692271b1525e414b0f645cdadb1f6
ToppCell	356C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|356C / Donor, Lineage, Cell class and subclass (all cells)	CACNA1D CLIP3 CBLN4 COL15A1 MAP1B CTHRC1 ARMH4	9.93e-08	177	94	7	db222faaecbe5600da39277243c4e7e764eb63c9
ToppCell	BAL-Severe-Epithelial-Epithelial-transitional_Epi\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CHL1 PTPN3 EXPH5 MUC16 MUC4 DNALI1 AHNAK2	1.99e-07	196	94	7	3e99a367b7d817e1f1221450fcec20ad7a7c7a2a
ToppCell	BAL-Severe-Epithelial-Epithelial-transitional_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CHL1 PTPN3 EXPH5 MUC16 MUC4 DNALI1 AHNAK2	1.99e-07	196	94	7	1efacc37bbfbd05b5d4db3dd10f6d9a238d23e31
ToppCell	COPD-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	BMPR2 NEO1 SLC26A2 RIN2 CD44 HIPK2 CMTM8	2.06e-07	197	94	7	30dbc05ea66892d2e18ff375ffa86d1db7bc4083
ToppCell	Severe_COVID-19-Epithelial-transitional_Epi\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	CHL1 PTPN3 EXPH5 MUC16 MUC4 DNALI1 AHNAK2	2.06e-07	197	94	7	5ad3cd4c77016e862041baac3076f8cc0f75c417
ToppCell	BAL-Severe-Epithelial-Epithelial-transitional_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CHL1 PTPN3 EXPH5 MUC16 MUC4 DNALI1 AHNAK2	2.06e-07	197	94	7	08b371309cd790b171ed76cabc7d910e71cd2835
ToppCell	BAL-Severe-Epithelial-Epithelial-transitional_Epi\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CHL1 PTPN3 EXPH5 MUC16 MUC4 DNALI1 AHNAK2	2.06e-07	197	94	7	9f49feee38647bbf964974aac96fa75602186b5c
ToppCell	BL-critical-LOC-Epithelial\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 PTPN3 EXPH5 MUC16 MUC4 DNALI1 AHNAK2	2.13e-07	198	94	7	6218a25b94d5fa2c69880539adf9c63bfe52dcd3
ToppCell	(02)_MMP9/10+-(2)_GFP_FOXI1\|(02)_MMP9/10+ / shred by cell type by condition	ZMYND11 BBX KIZ SMARCA2 TTC3 LRRFIP1 AHNAK2	2.20e-07	199	94	7	18a7f9ced4364f45b184bd529f32ef02c27779d3
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CHL1 PTPN3 AOPEP EXPH5 CPLANE1 MUC4 AHNAK2	2.28e-07	200	94	7	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	CBLN4 VILL ENTHD1 UNC13C CBLN1	3.89e-07	70	94	5	8d6bdf2e773e894a0db39fdff1fafc2474e03fcf
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	VILL EXPH5 ENTHD1 CBLN1 AHNAK2	6.27e-07	77	94	5	a799ccdb84014e978d9fbccf3d2fee8fbeac7b0c
ToppCell	Basal_cells-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	EPHB2 NRG1 AOPEP PLEKHG3 UNC13C AHNAK2	1.43e-06	166	94	6	aea2ae12e4746149ebc6da063ef694381c098f80
ToppCell	NS-moderate-d_07-13-Lymphoid-NK\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	COL15A1 MAP1B CSPG4 TET1 CTHRC1 FIGN	1.95e-06	175	94	6	f6cd24d22f62469319f9d244e3e5de527d3d4d94
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CHL1 DOCK3 CNTNAP3B KIZ SMARCA2 DLG2	2.22e-06	179	94	6	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	COL15A1 AOPEP CSPG4 CTHRC1 FIGN ARMH4	2.45e-06	182	94	6	03a5a02acd48f0eb210485348bfe0cd21f486215
ToppCell	COVID-19-kidney-Stressed_PCT\|kidney / Disease (COVID-19 only), tissue and cell type	CNTNAP3B NRG1 SLC36A1 ZFAT AOX1 FIGN	2.86e-06	187	94	6	acd305475f3609800af0d7bc68d83ef41228080b
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1D ANK2 MAP1B AKAP13 RFX6 TTC3	2.95e-06	188	94	6	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	Control-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	BMPR2 NEO1 SLC26A2 RIN2 DACH1 CMTM8	3.13e-06	190	94	6	7f3f419fffe02934b6f27b697f7a6401072491ed
ToppCell	NS-critical-d_07-13\|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 PTPN3 EXPH5 MUC16 CPLANE1 MUC4	3.97e-06	198	94	6	a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d
ToppCell	NS-critical-LOC-Epithelial\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CHL1 PTPN3 EXPH5 MUC16 MUC4 DNALI1	4.09e-06	199	94	6	d64adb68502be596ce55fb2cb63fe1cfa2c5f8ba
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CLIP3 ANK2 MAP1B AOX1 CTHRC1 FIGN	4.09e-06	199	94	6	21335475bbfbad8a6943b8076a6c1c67f3eec5d3
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital\|World / Primary Cells by Cluster	CHL1 NEO1 ANK2 MAP1B DLG2 TTC3	4.21e-06	200	94	6	6bbe8e1f3e91678f1bfb14945365c1578a59a604
ToppCell	Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	CLIP3 ANK2 TET1 AOX1 CTHRC1 FIGN	4.21e-06	200	94	6	cdaf462b1db29dab61038eeab5ddd3eef3386763
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer_Occipital-19\|World / Primary Cells by Cluster	CHL1 NEO1 ANK2 MAP1B DLG2 TTC3	4.21e-06	200	94	6	c831d9e0a7178e3634da45548f91fa9e8dc6557c
ToppCell	Thalamus\|World / BrainAtlas - Mouse McCarroll V32	PPP1R3A PTPN3 UNC13C FIGN AHNAK2	4.77e-06	116	94	5	5ddfb2dd5459ff6d7ae38163a38eae64fda283b7
ToppCell	Mild/Remission-B_naive-4\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	USF3 MGAT5 CIITA KAT6A PNPLA7	2.95e-05	169	94	5	c3a6179a64589a370108fea809b157839347759c
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CLIP3 MGAT5 MAP1B DACH1 ARMH4	3.04e-05	170	94	5	60bbd738c12e64e483485586c30057304884f5a6
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 NRG1 CD44 CTHRC1 AHNAK2	3.21e-05	172	94	5	0c2d0bb767e5ce089b42ad49e8b303a103de2d5c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 NRG1 CD44 CTHRC1 AHNAK2	3.21e-05	172	94	5	eeed177a03c116e9815a8e086d24efc9643b16a4
ToppCell	ASK454-Epithelial-Transformed_epithelium\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	NRG1 GTF2IRD2B FAM153A RIN2 DLG2	3.21e-05	172	94	5	3986f0f098ef5e096c8d9ee3d335b8404083701f
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Adult / Lineage, Cell type, age group and donor	DOCK3 CNTNAP3B NRG1 ANK2 DACH1	3.49e-05	175	94	5	4db1a3c284488b3f6de7568363f176d74e2a4587
ToppCell	Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231\|Adult / Lineage, Cell type, age group and donor	DOCK3 CNTNAP3B NRG1 ANK2 DACH1	3.49e-05	175	94	5	8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BMPR2 COL15A1 RIN2 CHD9 TASOR	3.58e-05	176	94	5	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CHL1 CLIP3 ANK2 TET1 CTHRC1	3.68e-05	177	94	5	3d955ea938a1d2fb1b6d68d4997fd454bd632dfc
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MGAT5 MAP1B EXPH5 DACH1 ARMH4	3.68e-05	177	94	5	4d2cdb57b427a42085c5f9affa0967b15e84dec3
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NRG1 VILL CBLN2 DACH1 AKAP13	3.78e-05	178	94	5	b169aa5eaa51730daaec69c6bc58126be1592a50
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP8AP2 BMPR2 TUT7 DACH1 TASOR	3.78e-05	178	94	5	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MGAT5 MAP1B EXPH5 DACH1 ARMH4	3.78e-05	178	94	5	edc7143dc9959d36057cb9471681a23afcbc8cce
ToppCell	wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ZFAT COL15A1 CSPG4 GTF2IRD2 AHNAK2	3.78e-05	178	94	5	a55130670aa95a87b833dd3cd2de461d779e4c06
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_3\|356C / Donor, Lineage, Cell class and subclass (all cells)	GTF2IRD2B USF3 KIZ PPM1B KPNB1	3.89e-05	179	94	5	f378307eb20f002450c748b7be2289d6db2fcbcb
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MGAT5 MAP1B EXPH5 DACH1 ARMH4	3.99e-05	180	94	5	d685fa2b013bc085dbef7c40956ed3043f83e483
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CBLN4 COL15A1 RIN2 FIGN CMTM8	4.10e-05	181	94	5	35bcdcd2651149692e5b150e887c0f450c81d2d4
ToppCell	5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLIP3 COL15A1 AOX1 CTHRC1 PNPLA7	4.10e-05	181	94	5	b116c68393d8836bac080f81a8fcbeb52e0403e7
ToppCell	Epithelial-lung_neuroendocrine_cell_(PNEC)\|World / Lineage, Cell type, age group and donor	DOCK3 CNTNAP3B NRG1 ANK2 RFX6	4.20e-05	182	94	5	57bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CBLN4 COL15A1 RIN2 FIGN CMTM8	4.20e-05	182	94	5	3d7a8d2ee2137b098248597058974ef5ae09c19e
ToppCell	droplet-Marrow-nan-3m-Hematologic-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP8AP2 TET1 CHD9 TTC3 TASOR	4.20e-05	182	94	5	e78ba2c5cae480c16a596ce7c3bf2d480becacf4
ToppCell	droplet-Marrow-nan-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASP8AP2 TET1 CHD9 TTC3 TASOR	4.20e-05	182	94	5	1710eab3037a87609d21838be2d2d29c3bc36651
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FAM153A COL15A1 MAP1B DACH1 FIGN	4.20e-05	182	94	5	44764676ed3f51ba171ce63f669390392fa50a43
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FAM153A COL15A1 MAP1B DACH1 FIGN	4.20e-05	182	94	5	d82f59a3f930a840dde27dc6ab024f227a26d446
ToppCell	COVID-19-kidney-Podocyte\|kidney / Disease (COVID-19 only), tissue and cell type	MGAT5 MAP1B EXPH5 DACH1 ARMH4	4.32e-05	183	94	5	fb5e2a31b560126e1c04a386c24c365901c60ad7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MGAT5 EXPH5 DACH1 DLG2 ARMH4	4.32e-05	183	94	5	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MGAT5 EXPH5 DACH1 DLG2 ARMH4	4.32e-05	183	94	5	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	P07-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	EPHB2 NRG1 COL15A1 CTHRC1 ARMH4	4.43e-05	184	94	5	01257e5c12e38b849fd3d9496c43ded666249ba5
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MGAT5 EXPH5 DACH1 DLG2 ARMH4	4.43e-05	184	94	5	7294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CBLN4 COL15A1 RIN2 FIGN CMTM8	4.54e-05	185	94	5	caf4f57f2db9ff72a652c8573e16e7ab180ffc05
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B EXPH5 UNC13C TTC3 CBLN1	4.66e-05	186	94	5	d1d01ce46e62944aa9864eda47e8401b5f0d2bdc
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	EPHB2 CHL1 CBLN4 ANK2 HIPK2	4.66e-05	186	94	5	4d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NRG1 COL15A1 AOPEP CBLN2 DACH1	4.66e-05	186	94	5	360c3e9e5c3a943e68e6939b4a47821bfc75b553
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CNTNAP3B EXPH5 CD44 DACH1 FIGN	4.78e-05	187	94	5	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MGAT5 MAP1B EXPH5 DACH1 ARMH4	4.78e-05	187	94	5	24c2a3962da364e46e98abeab5f8234376fa26bb
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MGAT5 MAP1B EXPH5 DACH1 ARMH4	4.91e-05	188	94	5	047c4e0b03fc8334e38c48977e41d26dbe229d47
ToppCell	COPD-Epithelial-Mesothelial\|COPD / Disease state, Lineage and Cell class	FAM153A MAP1B AOX1 MUC16 FIGN	5.03e-05	189	94	5	79bb2593ad5d17f94b17972884241f03a0f43770
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CHL1 BMPR2 RIN2 DACH1 CMTM8	5.03e-05	189	94	5	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_3\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	GTF2IRD2B USF3 KIZ PPM1B KPNB1	5.03e-05	189	94	5	99b01893da9f9f7c9528afaffad178285211738b
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B EXPH5 UNC13C TTC3 CBLN1	5.03e-05	189	94	5	f57200c93d39c9bce1adba0a6a1c178c028dd86b
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZMYND11 BMPR2 MAP1B KAT6A SMARCA2	5.16e-05	190	94	5	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	(4)_Endothelial_cells-(40)_EC-arterial\|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	COL15A1 CD44 DACH1 LRRFIP1 AHNAK2	5.16e-05	190	94	5	ff774faf3f12759d11e50ed7d189288bb79e22e1
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MGAT5 MAP1B EXPH5 DACH1 ARMH4	5.42e-05	192	94	5	ef0aba777072429a6ab7dcfcc305673975946580
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 KIZ DACH1 CHD9 UNC13C	5.42e-05	192	94	5	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	CNTNAP3B NRG1 BMPR2 RIN2 HIPK2	5.56e-05	193	94	5	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MGAT5 MAP1B EXPH5 DACH1 ARMH4	5.56e-05	193	94	5	3eaa0461618582a1754400624350d269d24e750a
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KAT6A DACH1 SMARCA2 HIPK2 CMTM8	5.56e-05	193	94	5	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KAT6A DACH1 SMARCA2 HIPK2 CMTM8	5.56e-05	193	94	5	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 CACNA1D ANK2 AOX1 DLG2	5.56e-05	193	94	5	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	CNTNAP3B NRG1 BMPR2 RIN2 HIPK2	5.56e-05	193	94	5	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1B EXPH5 UNC13C TTC3 CBLN1	5.56e-05	193	94	5	5fb7808dd971c1cc64c2bd4f8f1de646fb2d77f4
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 CACNA1D ANK2 AOX1 DLG2	5.69e-05	194	94	5	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 CACNA1D ANK2 AOX1 DLG2	5.69e-05	194	94	5	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	LA-09._Endothelium_I\|World / Chamber and Cluster_Paper	CNTNAP3B BMPR2 RIN2 DACH1 CMTM8	5.83e-05	195	94	5	fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 NEO1 MAP1B AOPEP AHNAK2	5.83e-05	195	94	5	eb2003d4f15cad213d17eda8ab7479f5a0c62164
ToppCell	distal-Hematologic-Basophil/Mast_1-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SLC26A2 CD44 ENTHD1 AKAP13 AHNAK2	5.83e-05	195	94	5	4f83449fce3717518e2acbba1a4b3bea765c0bdb
ToppCell	distal-2-Hematologic-Basophil/Mast_1\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SLC26A2 CD44 ENTHD1 AKAP13 AHNAK2	5.98e-05	196	94	5	ad21706a281f0b105eb3979e3e47fe0cec6c527f
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CHL1 VILL EXPH5 MUC16 MUC4	5.98e-05	196	94	5	b07db4a53ab9be9aad6fae5e45f9547db829d096
ToppCell	IPF-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	BMPR2 NEO1 SLC26A2 CD44 CMTM8	5.98e-05	196	94	5	8f0f72ead06abe02b575e443552eacc2151077ef
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CHL1 VILL EXPH5 MUC16 MUC4	5.98e-05	196	94	5	c366f980cc04abfe1c0c14746c11810c812a42c0
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EPHB2 CHL1 CACNA1D PTPN3 CD44	6.12e-05	197	94	5	7e93a97b5ac5ae2f77a4b3141082a1463fed00dd
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHL1 VILL SLC26A2 MUC16 MUC4	6.12e-05	197	94	5	ec08a971e8dd9ad69359896c60ad77ff8af08fd0
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHL1 MUC16 CPLANE1 MUC4 AHNAK2	6.12e-05	197	94	5	5c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCell	LA-09._Endothelium_I\|LA / Chamber and Cluster_Paper	CNTNAP3B BMPR2 RIN2 DACH1 CMTM8	6.12e-05	197	94	5	ab6d1ab586a188597a39854ef980b8955ebcc645
ToppCell	356C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	COL15A1 MAP1B AOPEP CSPG4 LRRFIP1	6.12e-05	197	94	5	71367bebc23d0e81f60f780d6b0ab3a1783ac014
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-AT1\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ZFAT ANK2 DLG2 FIGN BAHCC1	6.12e-05	197	94	5	f7ef62d78336812573148f8bfce401877ec4e29c
ToppCell	Bronchus_Control_(B.)\|World / Sample group, Lineage and Cell type	CHL1 NRG1 SLC26A2 MUC16 MUC4	6.12e-05	197	94	5	b6dff2ee108813e18657e2d8cf850e2423f8c8e9
ToppCell	356C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	COL15A1 MAP1B AOPEP CSPG4 LRRFIP1	6.12e-05	197	94	5	0f9836554ace3f9d155ebafdd719aa26466ca44e
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	CACNA1D NEO1 COL15A1 CTHRC1 DLG2	6.12e-05	197	94	5	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CHL1 VILL MUC16 MUC4 AHNAK2	6.27e-05	198	94	5	6e047de63ef59dcb47e4fc06b173b2a02fdcf4c9
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLIP3 NEO1 ANK2 HIPK2 GAB1	6.27e-05	198	94	5	a7e5de81eb7d3d23812c179a001adbaab1506596
Drug	Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A	EPHB2 BBX EXPH5 KAT6A HIPK2 AKAP13 CPLANE1 ZBTB14	1.08e-06	189	93	8	6649_DN
Drug	rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA	EPHB2 CACNA1D RIN2 AOX1 CTDP1 CD44 AKAP13 AHNAK2	1.27e-06	193	93	8	921_UP
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	BBX PRPF4 SLC26A2 EXPH5 CD44 HIPK2 AKAP13	8.53e-06	178	93	7	3998_DN
Drug	Strophanthidin [66-28-4]; Down 200; 9.8uM; PC3; HT_HG-U133A	PLEKHG3 CAMK2G RIN2 CD44 TASOR LRRFIP1 AHNAK2	1.49e-05	194	93	7	5826_DN
Drug	Betulin [473-98-3]; Down 200; 9uM; MCF7; HT_HG-U133A	AOPEP CAMK2G HMGXB3 QSER1 GAB1 KPNB1 BAHCC1	1.54e-05	195	93	7	3513_DN
Drug	Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A	RIN2 KAT6A CTDP1 HIPK2 GAB1 ZBTB14 SMG6	1.54e-05	195	93	7	3269_UP
Drug	Propidium iodide [25535-16-4]; Down 200; 6uM; MCF7; HT_HG-U133A	EPHB2 CACNA1D MAP1B RIN2 DACH1 QSER1 GAB1	1.70e-05	198	93	7	6104_DN
Drug	Letrozole [112809-51-5]; Down 200; 14uM; MCF7; HT_HG-U133A	EXPH5 RIN2 KAT6A AOX1 AKAP13 HMGXB3 ADAM17	1.82e-05	200	93	7	7336_DN
Drug	16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione	TUT7 AKAP13 FIGN AHNAK2	3.42e-05	45	93	4	ctd:C020175
Drug	Perphenazine [58-39-9]; Up 200; 10uM; MCF7; HT_HG-U133A	MAP1B CIITA CD44 HIPK2 RNF17 GAB1	1.19e-04	187	93	6	5698_UP
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	EPHB2 BBX MAP1B EXPH5 KAT6A AKAP13	1.34e-04	191	93	6	4279_DN
Drug	Syrosingopine [84-36-6]; Up 200; 6uM; MCF7; HT_HG-U133A	BBX CD44 HIPK2 ADAM17 GAB1 LRRFIP1	1.38e-04	192	93	6	6213_UP
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HG-U133A	BMPR2 BBX MAP1B CD44 HMGXB3 AHNAK2	1.38e-04	192	93	6	23_UP
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A	OVGP1 KAT6A CD44 SMARCA2 AKAP13 DNALI1	1.42e-04	193	93	6	4690_DN
Drug	AC1L1KGG	PTPN3 MGAT5 CD44	1.42e-04	25	93	3	CID000005489
Drug	DNA-PK Inhibitor III; Up 200; 1uM; MCF7; HT_HG-U133A	CACNA1D OVGP1 RIN2 SMARCA2 ADAM17 SMG6	1.46e-04	194	93	6	7543_UP
Drug	Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	DOCK3 OVGP1 CAMK2G HIPK2 AKAP13 SMG6	1.46e-04	194	93	6	4951_UP
Drug	Iopanoic acid [96-83-3]; Down 200; 7uM; MCF7; HT_HG-U133A	EPHB2 CAMK2G KAT6A CD44 GAB1 BAHCC1	1.46e-04	194	93	6	3527_DN
Drug	6-mercaptopurine monohydrate; Up 200; 100uM; MCF7; HG-U133A	SLC36A1 CIITA TUT7 CTDP1 CD44 ARMC6	1.46e-04	194	93	6	334_UP
Drug	Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A	EPHB2 CSPG4 HIPK2 QSER1 CPLANE1 AHNAK2	1.50e-04	195	93	6	5665_UP
Drug	Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	NRG1 CD44 QSER1 CBLN1 GAB1 BAHCC1	1.54e-04	196	93	6	6483_UP
Drug	5255229; Up 200; 13uM; MCF7; HT_HG-U133A_EA	EPHB2 CACNA1D OVGP1 HIPK2 ARMC6 SMG6	1.54e-04	196	93	6	833_UP
Drug	Alcuronium chloride [15180-03-7]; Up 200; 5.4uM; MCF7; HT_HG-U133A	EPHB2 CACNA1D MGAT5 HIPK2 RNF17 CCDC7	1.54e-04	196	93	6	4409_UP
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	JADE3 CTDP1 CD44 DACH1 SMARCA2 HMGXB3	1.54e-04	196	93	6	1629_DN
Drug	Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A	MAP1B PLEKHG3 KAT6A CTDP1 HMGXB3 ADAM17	1.54e-04	196	93	6	3233_DN
Drug	Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	MAP1B CAMK2G AOX1 CD44 AKAP13 QSER1	1.54e-04	196	93	6	2775_DN
Drug	Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; PC3; HG-U133A	BMPR2 KRT32 PLEKHG3 CTDP1 SMARCA2 AKAP13	1.54e-04	196	93	6	1904_UP
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A	EXPH5 KAT6A AOX1 HIPK2 AKAP13 BAHCC1	1.54e-04	196	93	6	4359_DN
Drug	Azlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; MCF7; HT_HG-U133A	CACNA1D MAP1B CD44 AKAP13 ADAM17 ARMC6	1.54e-04	196	93	6	3468_DN
Drug	Ioxaglic acid [59017-64-0]; Up 200; 3.2uM; MCF7; HT_HG-U133A	CTDP1 HIPK2 HMGXB3 GAB1 ZBTB14 SMG6	1.54e-04	196	93	6	7470_UP
Drug	Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; MCF7; HT_HG-U133A	EPHB2 CACNA1D SLC26A2 EXPH5 RIN2 DNALI1	1.54e-04	196	93	6	6000_UP
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A	MAP1B KAT6A CD44 DACH1 AKAP13 BAHCC1	1.59e-04	197	93	6	2259_DN
Drug	Suprofen [40828-46-4]; Down 200; 15.4uM; MCF7; HT_HG-U133A	MAP1B EXPH5 CTDP1 SMARCA2 SMG6 BAHCC1	1.59e-04	197	93	6	3343_DN
Drug	Cephapirin sodium salt [24356-60-3]; Up 200; 9uM; MCF7; HT_HG-U133A	EXPH5 CAMK2G RIN2 AOX1 DACH1 HMGXB3	1.59e-04	197	93	6	3471_UP
Drug	Hexestrol [84-16-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A	SLC36A1 EXPH5 RIN2 SMARCA2 KPNB1 BAHCC1	1.59e-04	197	93	6	6077_DN
Drug	Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A	OVGP1 HIPK2 AKAP13 HMGXB3 ARMC6 SMG6	1.59e-04	197	93	6	3195_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SLC26A2 CAMK2G RIN2 DACH1 SMARCA2 ZBTB14	1.63e-04	198	93	6	3332_DN
Drug	genistein; Down 200; 10uM; HL60; HT_HG-U133A	COL15A1 CSPG4 DACH1 HIPK2 ARMC6 BAHCC1	1.63e-04	198	93	6	6194_DN
Drug	5286656; Down 200; 50uM; MCF7; HT_HG-U133A_EA	CD44 SMARCA2 GAB1 DNALI1 ARMC6 BAHCC1	1.63e-04	198	93	6	889_DN
Drug	Ketoconazole [65277-42-1]; Down 200; 7.6uM; MCF7; HT_HG-U133A	NEO1 AOX1 CD44 SMARCA2 ADAM17 ARMC6	1.63e-04	198	93	6	2640_DN
Drug	Bromopride [4093-35-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	CACNA1D CD44 DACH1 ADAM17 GAB1 AHNAK2	1.63e-04	198	93	6	6037_DN
Drug	AC1L53UG	PTPN3 CD44	1.64e-04	5	93	2	CID000197691
Drug	Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A	CACNA1D AOX1 CD44 DACH1 HIPK2 QSER1	1.68e-04	199	93	6	6240_UP
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; PC3; HT_HG-U133A	CTDP1 AKAP13 ADAM17 ZBTB14 CCDC7 SMG6	1.68e-04	199	93	6	4297_DN
Drug	Leucomisine [17946-87-1]; Up 200; 16.2uM; MCF7; HT_HG-U133A	EPHB2 CHL1 MGAT5 COL15A1 CSPG4 GAB1	1.68e-04	199	93	6	3546_UP
Drug	Mefenamic acid [61-68-7]; Up 200; 16.6uM; MCF7; HT_HG-U133A	EPHB2 CACNA1D KRT32 SMARCA2 GAB1 SMG6	1.68e-04	199	93	6	5534_UP
Drug	Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	SLC26A2 KAT6A AOX1 CTDP1 SMARCA2 DNALI1	1.68e-04	199	93	6	7330_DN
Drug	Vidarabine [5536-17-4]; Down 200; 15uM; MCF7; HT_HG-U133A	EXPH5 CD44 DACH1 HMGXB3 ADAM17 ZBTB14	1.68e-04	199	93	6	3445_DN
Disease	asthma, response to diisocyanate	PTPN3 ZFAT TUT7 CTDP1 KLKP1 FIGN	1.51e-04	261	90	6	EFO_0006995, MONDO_0004979
Disease	lean body mass	ZFAT REPS1 KIZ AKAP13 TASOR PHC2 CMTM8	1.63e-04	379	90	7	EFO_0004995
Disease	triacylglycerol 52:4 measurement	DACH1 TASOR ZBTB14	1.82e-04	36	90	3	EFO_0010416
Disease	insulin sensitivity measurement, glucose homeostasis measurement	MGAT5 EXPH5 UNC13C	3.10e-04	43	90	3	EFO_0004471, EFO_0006896
Disease	red blood cell density measurement	NRG1 PTPN3 ZFAT CIITA AKAP13 TASOR MUC4 PHC2 ARMH4 SMG6	3.51e-04	880	90	10	EFO_0007978
Disease	colorectal health	CHL1 ZFAT EXPH5 PKD1L1 DLG2	3.84e-04	201	90	5	EFO_0008460
Disease	thiamine measurement	NRG1 CBLN2	4.07e-04	10	90	2	EFO_0010540
Disease	asthma	DOCK3 RAF1 MGAT5 COL15A1 SMARCA2 MUC16 UNC13C TASOR GAB1	4.81e-04	751	90	9	MONDO_0004979
Disease	testosterone measurement	DOCK3 RAF1 CACNA1D MGAT5 BBX ANK2 AOPEP RIN2 TUT7 DACH1 SMARCA2 KPNB1	4.90e-04	1275	90	12	EFO_0004908
Disease	response to ondansetron, QT interval	SLC36A1 REPS1	4.97e-04	11	90	2	EFO_0004682, EFO_0020997
Disease	hair colour measurement	CHL1 RAF1 NRG1 NEO1 CD44 AKAP13 UNC13C QSER1	5.89e-04	615	90	8	EFO_0007822
Disease	Malignant neoplasm of prostate	EPHB2 COL15A1 KAT6A AOX1 AKAP13 RFX6 KLKP1 MUC4	5.95e-04	616	90	8	C0376358
Disease	phosphocreatine measurement	MGAT5 RIN2	7.02e-04	13	90	2	EFO_0010521
Disease	juvenile rheumatoid arthritis (is_implicated_in)	CIITA SLC26A2	7.02e-04	13	90	2	DOID:676 (is_implicated_in)
Disease	response to opioid	MGAT5 CTDP1 MUC16	8.69e-04	61	90	3	EFO_0008541
Disease	Proteinuria	UNC13C SMG6	9.41e-04	15	90	2	HP_0000093
Disease	triiodothyronine measurement	EPHB2 DLG2	1.07e-03	16	90	2	EFO_0008392
Disease	t-tau:beta-amyloid 1-42 ratio measurement	ZFAT OVGP1 DLG2	1.09e-03	66	90	3	EFO_0007708
Disease	bacteriemia	DOCK3 CBLN2	1.21e-03	17	90	2	EFO_0003033
Disease	waist-hip ratio	EPHB2 PPP1R3A ZMYND11 ZFAT COL15A1 BBX CIITA DLG2 ADAM17 FIGN SMG6	1.26e-03	1226	90	11	EFO_0004343
Disease	visceral:subcutaneous adipose tissue ratio	CACNA1D ZFAT ADAM17	1.30e-03	70	90	3	EFO_0004767
Disease	urate measurement	DOCK3 NRG1 BMPR2 NEO1 MGAT5 CSPG4 DACH1 DLG2 AKAP13	1.64e-03	895	90	9	EFO_0004531
Disease	Diuretic use measurement	CACNA1D DACH1 AKAP13 FIGN	1.81e-03	169	90	4	EFO_0009928
Disease	Hodgkins lymphoma	AOPEP ENTHD1 CPLANE1	2.04e-03	82	90	3	EFO_0000183
Disease	response to selective serotonin reuptake inhibitor	NRG1 ZFAT REPS1	2.04e-03	82	90	3	EFO_0005658
Disease	urinary albumin to creatinine ratio	AOPEP UNC13C PHC2 BAHCC1	2.23e-03	179	90	4	EFO_0007778
Disease	response to anticonvulsant	ANK2 RIN2 DACH1	2.26e-03	85	90	3	GO_0036277
Disease	multiple sclerosis	MGAT5 CAMK2G CBLN2 ENTHD1 AKAP13 KPNB1 SMG6	2.29e-03	594	90	7	MONDO_0005301
Disease	blood urea nitrogen measurement	NRG1 DACH1 CHD9 AKAP13 GAB1 PHC2	2.63e-03	452	90	6	EFO_0004741
Disease	triacylglycerol 52:6 measurement	BBX DACH1	2.64e-03	25	90	2	EFO_0010418
Disease	Prostatic Neoplasms	COL15A1 KAT6A AOX1 AKAP13 RFX6 KLKP1 MUC4	2.80e-03	616	90	7	C0033578
Disease	platelet measurement	SIRPD SLC36A1 CHD9 TASOR SMG6	2.82e-03	315	90	5	EFO_0005036
Disease	amygdala volume change measurement, age at assessment	AOPEP CTHRC1	2.85e-03	26	90	2	EFO_0008007, EFO_0021490
Disease	birth weight, parental genotype effect measurement	USF3 AKAP13 RFX6 ADAM17	2.87e-03	192	90	4	EFO_0004344, EFO_0005939

Protein segments in the cluster

Peptide	Gene	Start	Entry
TSTMSPEEVEQHMRN	SMG6	561	Q86US8
QQVPLSTATVSMVHS	CTDP1	141	Q9Y5B0
VHSSNLEDPETMQTT	BAHCC1	1106	Q9P281
HNTEVGETRSSTPEM	BBX	876	Q8WY36
SEMDRQSHPVAFTVT	CSPG4	1451	Q6UVK1
GSPEMNSTINIHRTS	CTHRC1	181	Q96CG8
SSMERHEETLTTPQL	CCDC7	631	Q96M83
TSRANMTEHKTSPTQ	CIITA	306	P33076
ESIVAAMTQHLTSPQ	ARMC6	371	Q6NXE6
TQVRTEMSQTAQVSH	ARMH4	336	Q86TY3
QAHDTSSLPTVIMRN	AKAP13	1851	Q12802
VSRSSVSHSVLSEMQ	ARFGAP2	311	Q8N6H7
HIPVTNARTFSSEME	AOPEP	81	Q8N6M6
THEEQSSMIQTQVPD	CASP8AP2	1611	Q9UKL3
KRTQSVTSPENSHIM	DACH1	291	Q9UI36
PMSNVHLRGTSTETV	AOX1	1066	Q06278
LSQRQRSTSTPNVHM	RAF1	251	P04049
VRHVTSDFNSMTATV	QSER1	896	Q2KHR3
SMVNQHVSVISSIRS	RFX6	816	Q8HWS3
REMLVTNTQTGEEHT	PTPN3	786	P26045
ESHSVIVMSSVENSR	NRG1	366	Q02297
IVMSSVENSRHSSPT	NRG1	371	Q02297
VMDDSVVIPSHQVST	ANK2	921	Q01484
QDVHLPTETMLSQET	ENTHD1	211	Q8IYW4
TMSPTHVTQSLKDQT	MUC16	1561	Q8WXI7
DTEDMQPSTHTAVTN	MUC16	8341	Q8WXI7
SSNRIHIPDSDQSTM	MUC16	9916	Q8WXI7
MLDRHTSQQITTAPS	MUC4	601	Q99102
LSSQVNEEHSPVSRM	FIGN	591	Q5HY92
TMTTENPNQTVVSHF	OR10S1	11	Q8NGN2
GVAHVMRQQPTSTTS	HIPK2	786	Q9H2X6
SRTPVQDHRSEQSSM	MAP1B	1631	P46821
EEETVTNHTLRVMTP	CHL1	761	O00533
LDSQTPHMVINSVAT	MGAM2	2451	Q2M2H8
HFTIQQRTQPESSSM	MGAT5	31	Q09328
SGTSSVETQMRHVSI	GAB1	291	Q13480
SRIQEASHSQVLTMT	KRT32	126	Q14532
VDMTETEHSIQHPVT	HMGXB3	1151	Q12766
PSAVSIMHQVSRTVD	EPHB2	436	P29323
PGQTVSEEATEVHTM	FAM153A	121	Q9UHL3
MRSHTEVTVTSSNSV	EXPH5	666	Q8NEV8
MSPVHRSRTSQTQEA	KLKP1	1	Q107X0
PAVSSVSKQETIMRH	GATAD2B	491	Q8WXI9
MPVTASVLSEEEQTH	KIZ	236	Q2M2Z5
QTMSHLPQVQSTTVT	RBM4B	246	Q9BQ04
SVMVAEIPSTVSQHS	PNPLA7	421	Q6ZV29
THQPSEETTSNMGEI	PPP1R3A	401	Q16821
EQPSHDTSVVSEQMA	KAT6A	1376	Q92794
TSHLVTRPSDMAQTQ	CHD9	441	Q3L8U1
AIRSTNHEPSEMSNR	CBLN1	66	P23435
VQQSTSQVDTMRPRH	DOCK3	191	Q8IZD9
HSNPEVLLQTTTRMT	CD44	331	P16070
GHTTPQSMQVDTSSE	CPLANE1	1976	Q9H799
MNTINAAEPHVVTVT	BMPR2	791	Q13873
VRSTNHEPSEMSNKT	CBLN4	76	Q9NTU7
TNHEPSEMSNRTMTI	CBLN2	101	Q8IUK8
STPSTRMDVVHLQEQ	DNALI1	91	O14645
NVTNPNSTEHMKEST	KPNB1	136	Q14974
VMVATNTPHSTLSVN	GLMP	81	Q8WWB7
SQHSTATRQPSMTLQ	DLG2	396	Q15700
VHQVTMTQPKRTFTT	CLIP3	501	Q96DZ5
SHPSSTSNEVIEMEL	GTF2IRD2	251	Q86UP8
SHPSSTSNEVIEMEL	GTF2IRD2B	251	Q6EKJ0
TLETTNMSIIQHSSP	COL15A1	301	P39059
ASNRMSSVVSEPHVI	PKD1L1	571	Q8TDX9
MPTSETESVNTENVS	CACNA1D	466	Q01668
SSVHSIRNMQVPQES	JADE3	571	Q92613
QTAMEPQTTVVHNAT	CAMK2G	361	Q13555
VTQIVMTDTGQPHSE	CNTNAP3B	761	Q96NU0
STERCEMSEHPSQTV	LRRFIP1	746	Q32MZ4
TMTPVHFQTETLRQN	OVGP1	546	Q12889
TLLTMHPASVQDQTT	REPS1	241	Q96D71
ESSQMSDLPVKVTHT	SMARCA2	586	P51531
FPRNSSSTQMVVHEI	RNF165	196	Q6ZSG1
MPVSTSLHQDGSQER	PLEKHG3	1	A1L390
EIPETTRTSQMQELH	PRPF4	201	O43172
RVENTSHPGEMQVTI	NEO1	486	Q92859
PVTMQESHTESESGL	PPM1B	446	O75688
HSTSALTEVEMNQPQ	TASOR	1151	Q9UK61
TSTVHVVNTTVVTMP	TET1	551	Q8NFU7
TTMTQHSRTQEGTEE	AHNAK2	5536	Q8IVF2
HQRMDTIQEDPSTDS	ADAM17	756	P78536
MEEPQRARSHTVTTT	CMTM8	1	Q8IZV2
EMTDVSVTVCHINSP	RNF17	676	Q9BXT8
ARTETQTSMPETVNH	RIN2	326	Q8WYP3
MHSERKQVTPSAIQS	ZBTB14	411	O43829
PQQDHTTTTDSEMEE	PHC2	611	Q8IXK0
TNHPEVSMSTISEVL	ZFAT	851	Q9P243
TEEEPSSNHTVMIQE	ZFAT	1166	Q9P243
SSTENQAQSTHTMPV	UNC13C	136	Q8NB66
HNNETVILTPTMDSR	SLC36A1	181	Q7Z2H8
MSSESKEQHNVSPRD	SLC26A2	1	P50443
STSAVTNIPHVQMVA	TTC3	1451	P53804
HVQQTEMSQTVSTGE	SIRPD	31	Q9H106
SVQKSNPMRITESHA	USF3	1916	Q68DE3
TDSHNTRTMEVPARA	VILL	516	O15195
SSPRMLHRSTQTTND	ZMYND11	446	Q15326
THSVQGQTSEMIPSD	TUT7	831	Q5VYS8
SQRKTNSEVPMHRSA	PJA1	46	Q8NG27